BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7543572)

  • 61. Pharmacological modulation of neuropeptides in peripheral mononuclear cells.
    Sacerdote P; Rubboli F; Locatelli L; Ciciliato I; Mantegazza P; Panerai AE
    J Neuroimmunol; 1991 Apr; 32(1):35-41. PubMed ID: 1672130
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro methionine5-enkephalin degradation kinetics by human brain preparations.
    Mosnaim AD; Nguyen TD; Tse R; Puente J; Couceyro P; Wolf ME
    Neurochem Res; 2008 Jan; 33(1):81-6. PubMed ID: 17676390
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The developmental pattern of met-enkephalin innervation is altered in animals perinatally exposed to morphine.
    Tenconi B; La Croix R; Donadoni ML; Di Giulio AM; Mantegazza P; Gorio A
    Pharmacol Res; 1989; 21 Suppl 1():61-2. PubMed ID: 2483754
    [No Abstract]   [Full Text] [Related]  

  • 64. Degradation of substance P by neuronal and glial cells cultured from rat fetal brain and their membranes.
    Endo S; Yokosawa H; Ishii S
    Neuropeptides; 1989 Jul; 14(1):31-7. PubMed ID: 2476683
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of hypoxia on neuropeptide levels in the rabbit superior cervical ganglion.
    Hanson G; Jones L; Fidone S
    J Neurobiol; 1986 Jan; 17(1):51-4. PubMed ID: 2425052
    [No Abstract]   [Full Text] [Related]  

  • 66. Processing and degradation of Met-enkephalin by peptidases associated with rat brain cortical synaptosomes.
    Demmer W; Brand K
    Adv Exp Med Biol; 1984; 167():165-77. PubMed ID: 6369904
    [No Abstract]   [Full Text] [Related]  

  • 67. Regional heterogeneity within the nucleus accumbens concerning the effects of dopaminergic agents on the content of cholecystokinin.
    Yoshikawa T; Fukamauchi F; Shibuya H; Takahashi R
    Neurochem Int; 1989; 14(4):467-9. PubMed ID: 20504451
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuropathological findings in chorea-acanthocytosis: new insights into mechanisms underlying parkinsonism and seizures.
    Connolly BS; Hazrati LN; Lang AE
    Acta Neuropathol; 2014 Apr; 127(4):613-5. PubMed ID: 24394886
    [No Abstract]   [Full Text] [Related]  

  • 69. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neuropeptide influences on the development of their receptors.
    Handelmann GE
    Prog Brain Res; 1988; 73():523-33. PubMed ID: 2458616
    [No Abstract]   [Full Text] [Related]  

  • 71. Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.
    Waters SM; Konkoy CS; Davis TP
    J Pharmacol Exp Ther; 1995 Aug; 274(2):783-9. PubMed ID: 7543572
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Haloperidol and apomorphine differentially affect neuropeptidase activity.
    Waters SM; Konkoy CS; Davis TP
    J Pharmacol Exp Ther; 1996 Apr; 277(1):113-20. PubMed ID: 8613907
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices.
    Konkoy CS; Waters SM; Davis TP
    J Pharmacol Exp Ther; 1994 May; 269(2):555-63. PubMed ID: 7910209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases.
    Konkoy CS; Davis TP
    J Neurochem; 1995 Dec; 65(6):2773-82. PubMed ID: 7595577
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of lithium and haloperidol administration on the rat brain levels of substance P.
    Hong JS; Tilson HA; Yoshikawa K
    J Pharmacol Exp Ther; 1983 Mar; 224(3):590-3. PubMed ID: 6186804
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modification of inherent and drug-induced dopaminergic activity after exposure to benzo(alpha)pyrene.
    Konstandi M; Harkitis P; Thermos K; Ogren SO; Johnson EO; Tzimas P; Marselos M
    Neurotoxicology; 2007 Jul; 28(4):860-7. PubMed ID: 17570529
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.